Nu Skin Enterprises, Inc. (NYSE:NUS) General Counsel D Matthew Dorny sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $60.88, for a total transaction of $456,600.00. Following the completion of the transaction, the general counsel now owns 52,230 shares in the company, valued at $3,179,762.40. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

D Matthew Dorny also recently made the following trade(s):

  • On Wednesday, July 5th, D Matthew Dorny sold 8,250 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $62.92, for a total transaction of $519,090.00.
  • On Monday, June 5th, D Matthew Dorny sold 8,000 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $56.39, for a total transaction of $451,120.00.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) traded down 7.45% during midday trading on Monday, reaching $56.01. 2,902,606 shares of the company traded hands. The company’s 50 day moving average is $62.65 and its 200-day moving average is $56.54. The stock has a market capitalization of $2.97 billion, a price-to-earnings ratio of 18.73 and a beta of 1.31. Nu Skin Enterprises, Inc. has a 12 month low of $46.35 and a 12 month high of $66.04.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.08. The firm had revenue of $550.10 million for the quarter, compared to analysts’ expectations of $548.09 million. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. Nu Skin Enterprises’s revenue was down 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.79 earnings per share. Equities research analysts forecast that Nu Skin Enterprises, Inc. will post $3.23 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th will be given a dividend of $0.36 per share. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a yield of 2.57%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 48.81%.

TRADEMARK VIOLATION WARNING: “D Matthew Dorny Sells 7,500 Shares of Nu Skin Enterprises, Inc. (NUS) Stock” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/08/14/d-matthew-dorny-sells-7500-shares-of-nu-skin-enterprises-inc-nus-stock.html.

NUS has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $63.00 price objective on the stock in a report on Wednesday, April 26th. Sidoti lowered shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 price objective on the stock. in a report on Wednesday, April 26th. Pivotal Research restated a “buy” rating and issued a $65.00 price objective on shares of Nu Skin Enterprises in a report on Thursday, May 4th. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Finally, Deutsche Bank AG upped their price objective on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the stock a “buy” rating in a report on Wednesday, June 21st. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $62.88.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Nu Skin Enterprises by 0.4% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 7,249 shares of the company’s stock worth $456,000 after buying an additional 31 shares during the period. Independent Portfolio Consultants Inc. boosted its position in shares of Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock worth $132,000 after buying an additional 40 shares during the period. US Bancorp DE boosted its position in shares of Nu Skin Enterprises by 3.3% in the second quarter. US Bancorp DE now owns 2,032 shares of the company’s stock worth $128,000 after buying an additional 65 shares during the period. Loudon Investment Management LLC boosted its position in shares of Nu Skin Enterprises by 1.2% in the second quarter. Loudon Investment Management LLC now owns 8,675 shares of the company’s stock worth $545,000 after buying an additional 100 shares during the period. Finally, Suntrust Banks Inc. boosted its position in shares of Nu Skin Enterprises by 1.3% in the first quarter. Suntrust Banks Inc. now owns 8,117 shares of the company’s stock worth $450,000 after buying an additional 102 shares during the period. 84.53% of the stock is currently owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.